{
"NDC": {
"NDCCode": "69097-361-08",
"PackageDescription": "120 mL in 1 BOTTLE (69097-361-08) ",
"NDC11Code": "69097-0361-08",
"ProductNDC": "69097-361",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Grisofulvin",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Grisofulvin",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20170306",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA065354",
"LabelerName": "Cipla USA Inc.",
"SubstanceName": "GRISEOFULVIN",
"StrengthNumber": "125",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-03-28",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20170306",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}